Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in México from 2014 to 2017

• Published in: PloS one Vol. 15; no. 3; p. e0230576
• Main Authors: Morales-Ríos, Olga, Cicero-Oneto, Carlo, García-Ruiz, Carlos, Villanueva-García, Dina, Hernández-Hernández, Maribelle, Olivar-López, Víctor, Jiménez-Juárez, Rodolfo Norberto, Jasso-Gutiérrez, Luis
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 2020; Public Library of Science (PLoS)
• Subjects: Acute Kidney Injury - etiology; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Algorithms; Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Biology and Life Sciences; Body mass index; Causality; Child; Child, Preschool; Children; Complications; Drug-Related Side Effects and Adverse Reactions - epidemiology; Drug-Related Side Effects and Adverse Reactions - mortality; Drug-Related Side Effects and Adverse Reactions - pathology; Drugs; Emergency medical care; Emergency medical services; Female; Gender; Hospitals; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Infectious diseases; Male; Malnutrition; Medical diagnosis; Medicine and Health Sciences; Mexico - epidemiology; Morbidity; Mortality; Neoplasms; Neoplasms - diagnosis; Neoplasms - drug therapy; Neutropenia; Patients; Pediatrics; Pharmaceutical industry; Pharmacovigilance; Sepsis; Severity of Illness Index; Sex Factors; Side effects; Tertiary Healthcare; Young Adult; Mexico
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0230576

In Pediatrics, adverse drug reactions (ADRs) affect morbidity and mortality. In Mexico, the characteristics of ADRs and suspect drugs have not been described in hospitalized children. To estimate the frequency of ADRs and describe them, as well as suspect drugs, in a tertiary care pediatric hospital in Mexico. A total of 1,649 Hospital Infantil de Mexico Federico Gómez ADR reports were analyzed. Completeness of the information was assessed, and ADRs severity and seriousness were assigned based on NOM-220-SSA1-2012, with causality being established according to the Naranjo algorithm. ADRs were classified with WHO Adverse Drug Reaction Terminology (WHO-ART). The drugs involved in ADRs were categorized according to the Anatomical Therapeutic Chemical (ATC) classification. Descriptive analysis was performed using the SPSS 20 statistical package. Of all the reports, 5.8% lacked sufficient information for the analysis (grade 0). ADRs frequency ranged from 2.12% to 8.07%. ADRs occurred most commonly in children (56.9%), in the female gender (52%), in subjects with normal BMI Z-score (46.6%) and malnutrition (35.3%), diagnosed with neoplasms (72.2%) and in the Emergency Department (70.0%). ADRs were severe in 14.4% of cases, in 81.0% they were serious and 2.1% were classified as definite. Most common serious ADR was febrile neutropenia (44.5%). The 0.7% of patients recovering with sequelae; 1.1% died (with the medication being associated) and 70.3% were admitted to the hospital as a result of an ADR. Antineoplastic and immunomodulating agents were more commonly associated with serious ADRs. ADRs affected morbidity and mortality, which is why strengthening pharmacovigilance programs in Mexican pediatric hospitals is necessary.